ArticleEBioMedicine2019
Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
Carlos Lopez-Gomez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it